BP000160-CYT-372: Recombinant Mouse Interleukin-7 (IL-7) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of murine 2E8 cells is < 0.2 ng/ml, corresponding to a Specific Activity of 5 MIU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000160-CYT-485: Recombinant Human Interleukin-7 (IL-7) Protein, His Tag
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000160-CYT-298: Recombinant Human Interleukin-7 (IL-7) Protein, Yeast
Source: Saccharomyces cerevisiae-derived.
The ED50 as determined by the dose-dependent stimulation of thymidine uptake by murine pre-B cell line 2E8 is < 0.5 ng/mL, corresponding to a specific activity of 2 MU/mg.
Purity: > 98% by SDS-PAGE.BP000156-CYT-667: Recombinant Human Interleukin 33 (IL-33) Protein, His Tag
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE.BP000156-CYT-425: Recombinant Human Interleukin 33 (IL-33) Protein
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000153-CYT-371: Recombinant Mouse Interleukin-3 (IL3) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of murine M-NFS-60 cells is < 0.05 ng/ml, corresponding to a Specific Activity of 20,000,000 IU/mg.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000153-CYT-210: Recombinant Human Interleukin-3 (IL3) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of TF-1 cells is < 0.1 ng/ml, corresponding to a Specific Activity of 10,000,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000153-CYT-156: Recombinant Rhesus Macaque Interleukin-3 (IL3) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of human TF-1 cells is less than 0.1 ng/ml, corresponding to a Specific Activity of 10,000,000 IU/mg.
Purity: > 97.0% by SDS-PAGE.BP000153-CYT-096: Recombinant Human Interleukin-3 (IL3) Protein, HEK
Source: HEK-derived.
The activity was determined by the dose dependent stimulation of the proliferation of human TF-1 cells (human erythroleukemic indicator cell line) and is typically 0.5-2 ug/ml.
Purity: > 90% as obsereved by SDS-PAGE.BP002450-CYT-105: Recombinant Human Interleukin-28B (IL-28B) Protein
Source: HEK-derived.
The specific activity was determined by the dose dependent protection of the cytopathic effect on A549 cells (human lung adenocarcinoma epithelial cell line) that were challenged with encephalomyocarditis (EMC) virus and is typically 0.1-1 ng/ml.
Purity: > 95% as obsereved by SDS-PAGE.